| Clinical data | |
|---|---|
| Other names | Reposamal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C14H18N2O3 |
| Molar mass | 262.309 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Reposal is abarbiturate derivative invented in the 1960s in Denmark. It hassedative,hypnotic andanticonvulsant properties, and was used primarily for the treatment ofinsomnia.[1][2][3]